Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0IDOZG
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
Alpha-human dectin-1-pam3 conjugate
|
|||||
| Synonyms |
Alpha-human Dectin-1-Pam3 conjugate (Dynavax Technologies)
Click to Show/Hide
|
|||||
| Organization |
Dynavax Technologies Corp.
|
|||||
| Drug Status |
Clinical candidate
|
|||||
| Indication |
In total 2 Indication(s)
Inflammation [ICD11:1A00-CA43]
Clinical candidate
Solid tumors [ICD11:2A00-2A0Z|2B50-2F9Z]
Clinical candidate
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
C-type lectin domain family 7 member A (CLEC7A)
|
Antigen Info | ||||
| Payload Name |
NAMPT toxophore
|
Payload Info | ||||
| Therapeutic Target |
Nicotinamide phosphoribosyltransferase (NAMPT)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.